NEC OncoImmunity AS

About:

NEC OncoImmunity AS is an artificial intelligence driven biotech company.

Website: https://www.oncoimmunity.com

Twitter/X: OncoImmunity

Top Investors: EASME - EU Executive Agency for SMEs, Coalition for Epidemic Preparedness Innovations

Description:

NEC OncoImmunity AS is an artificial intelligence (AI) driven biotech company offering proprietary machine-learning based software, which addresses the key knowledge gaps in the prediction of bona fide immunogenic antigens for personalized cancer immunotherapy and infectious disease vaccines.

Total Funding Amount:

$7.35M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Oslo, Oslo, Norway

Founded Date:

2014-01-01

Founders:

Richard Stratford, Trevor Clancy

Number of Employees:

11-50

Last Funding Date:

2022-04-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai